{"Name":"True North Therapeutics","perma":"true-north-therapeutics","BasicInfo":{"funded":"2013-01-01","isClosed":false,"closed":null,"short":"True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases."},"FundingRounds":[{"funding_type":"venture","series":"D","announcedDate":"2016-10-18","moneyRaised":45000000},{"funding_type":"venture","series":"C","announcedDate":"2015-12-03","moneyRaised":40000000},{"funding_type":"venture","series":"B","announcedDate":"2015-04-07","moneyRaised":35000000},{"funding_type":"venture","series":"A","announcedDate":"2014-06-17","moneyRaised":22000000}],"Acquisitions":[],"AcquiredBy":null,"IPO":null,"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"Co-Founder and CEO","started":null,"ended":null,"firstName":null,"lastName":null}],"PastTeam":[]}
